The Therapy

Patented Catheter

At Ambusol, we are redefining cancer treatment with a groundbreaking therapy for glioblastoma (GBM) – one of the most aggressive and deadly brain cancers.

Unlike traditional therapies such as surgery, radiation, and chemotherapy, which often last more than a year and cause severe side effects, our treatment is designed to be gentle, precise, and highly effective.

How it Works

Our method uses an artificial amino acid that glioblastoma cells absorb four times faster than healthy cells. This unique mechanism creates an osmotic imbalance that leads to targeted cancer cell death – without harming surrounding brain tissue.

The therapy is delivered through a patented catheter system that ensures local precision, allowing both administration of the therapy and removal of necrotic tissue.

Key Benefits

  • Only 7 days of treatment compared to the standard 13 months of conventional therapies
  • No observed side effects, preserving patients’ quality of life
  • Highly targeted – kills cancer cells while sparing healthy brain tissue
  • Proven long-term survival, with patients living years beyond the expected prognosis

 

A Breakthrough for Patients

In clinical cases where conventional therapies had failed, Ambusol’s therapy has shown remarkable results. One patient remains tumor-free 8 years after treatment, another for 2.5 years – outcomes nearly unheard of in recurrent glioblastoma.

Our Vision

Ambusol’s mission is to bring a more humane, effective, and life-extending therapy to cancer patients worldwide. With strong scientific foundations, patented technology, and growing global partnerships, we are committed to transforming the future of cancer care.